ArticleKidney international reports2026

Response to the Letter to the Editor entitled "Kidney Outcomes With Rituximab Versus Cyclophosphamide in Crescentic ANCA-Associated Glomerulonephritis: Contextualizing Observational Findings".

Federica Mescia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.